Patients and Parents as PIs: The Rise of Family-Led Science 

Families affected by rare diseases are increasingly moving from advocacy into active scientific leadership. Parents, and patients themselves, are funding research, building patient registries, launching foundations, partnering directly with scientists, and, in some cases, creating biotech companies to accelerate therapies that traditional systems have not delivered quickly enough. Drawing on both lived experience and a deep sense of urgency, these family and patient leaders are helping to shape research priorities, influence study design, generate critical data resources, and drive innovation across the rare disease ecosystem. The result is a new model of biomedical discovery—one that blends patient-centered insight, philanthropy, entrepreneurship, and hands-on participation in the execution of research to advance treatments and improve outcomes.